Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021
July 27 2021 - 8:00AM
Talis Biomedical Corporation ("TLIS"), a company dedicated to
developing innovative molecular diagnostic tests for infectious
diseases at the point-of-care, today announced that it will release
financial results for the second quarter after market close on
Tuesday, August 10, 2021. Talis will host a conference call,
beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to
discuss financial and operational results.
Interested parties may access the live call via telephone by
dialing 833-715-1329 for participants in the U.S. or Canada and
430-775-1933 for international callers, using conference ID
5966606. A live and archived webcast of the event can be accessed
via the News & Events page of the investor section of Talis
Biomedical’s website at www.talis.bio.
About Talis BiomedicalTalis is dedicated to
transforming diagnostic testing by developing and commercializing
innovative products that are designed to enable accurate, low cost
and rapid molecular testing for infectious diseases at the
point-of-care, beginning with COVID-19. The company is developing
Talis One, a compact, sample-to-answer, cloud-enabled, molecular
diagnostic platform. Talis is headquartered in Menlo Park,
California. For more information, please visit talis.bio.
ContactMedia & InvestorsEmily
Faucetteir@talisbio.com415-595-9407
Talis Biomedical (NASDAQ:TLIS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Talis Biomedical (NASDAQ:TLIS)
Historical Stock Chart
From Sep 2023 to Sep 2024